登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Results by treatment arm.
Results by treatment arm.
收藏
NIAID Data Ecosystem
2026-03-11 收录
临床试验效果分析
治疗组比较
数据链接：
https://figshare.com/articles/dataset/Results_by_treatment_arm_/11975847
数据链接
链接失效反馈
官方服务：
问题咨询
购买咨询
在线客服
NEW
资源简介：
Results by treatment arm.
应用场景：
创建时间：
2020-03-12
相关数据集
10(Framingham Equation) categories by treatment arm at baseline and 48 weeks.
心血管风险评估
临床试验效果分析
10(Framingham Equation) categories by treatment arm at baseline and 48 weeks.
NIAID Data Ecosystem
9
0
Incidence of Adverse Events by Study Group.
药物安全监测
临床试验效果分析
Incidence of Adverse Events by Study Group.
Digital Science - Figshare
2026-03-27 更新
5
0
Changes in outcome parameters after treatment with empagliflozin and placebo.
糖尿病药物疗效
临床试验效果分析
Changes in outcome parameters after treatment with empagliflozin and placebo.
NIAID Data Ecosystem
4
0
Summary of treatment outcomes based on PP analysis stratified by age.
临床试验效果分析
年龄分层治疗效果
Summary of treatment outcomes based on PP analysis stratified by age.
NIAID Data Ecosystem
6
0
Supplementary Material for: Bevacizumab with Erlotinib as First-line Therapy in Asian Patients with Advanced Hepatocellular Carcinoma: A Multicenter Phase II Study
细胞癌靶向治疗
临床试验效果分析
Objectives: The bevacizumab/erlotinib combination was reported with high clinical activity for advanced hepatocellular carcinoma (HCC) by a phase II study conducted in the USA. This multicenter study
NIAID Data Ecosystem
4
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广
